Type III Food Hypersensitivities

In North America, more than half of people suffering with Type III food hypersensitivities (known as IgE-mediated food intolerances) do not even know the cause. Because of the delayed reaction of these allergies, the origin of the resulting chronic pain often remains undetectable by traditional methods.

Adding to the frustration of simply identifying which of these allergens could be affecting you is the fact that they relate to such a wide variety of diseases and illnesses – including chronic fatigue, colitis and Crohn’s disease, celiac disease, atopic eczema, Type 2 diabetes, insomnia, hyperactivity, arthritis and joint pain, and muscle and back pain.

The ImuPro test, developed in Germany by R-Biopharm Laboratories and administered in North America exclusively by the LSIA Medical Laboratory, is the only test available in North America that can detect Type III allergies attributable to over 270 foods as well as to additives found in many food products.

Cholesterol management and cardiovascular disease incidence

An estimated 70,000 heart attack incidences occur in Canada annually. It has been reported that 50% of people diagnosed with coronary artery disease (CAD) had normal lipid levels. Furthermore, only 30% of all heart attacks can be explained with the analytical measurement of total cholesterol quantity.

Physicians can now play a more active role in identifying, reviewing and monitoring diseases of the coronary arteries through the analysis of LDL sub-fractions by using electrophoresis. This test, originally offered by the Scientific Laboratory for Food Intolerance, remains the only diagnostic tool approved by the FDA for the analysis of LDL sub-fractions.